Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

BlueLinx Completes $40 Mln Rights Offering

BlueLinx Holdings Inc. (BXC: Quote) said Friday that it has completed its previously announced $40 million rights offering.

The company said previously that it would use the net proceeds of the rights offering of about $38.7 million to reduce the outstanding balance of its U.S. revolving credit facility.

Following the issuance of the newly subscribed shares, which is expected to occur on or about April 1, BlueLinx will have about 86.6 million total shares outstanding.

After giving effect to the offering, Cerberus ABP Investor LLC beneficially owns about 54.4% of BlueLinx' common stock.

Concurrent with the completion of the rights offering, BlueLinx's previously announced amendment and extension to its $400 million U.S. revolving credit facility became effective. As a result of the amendment and extension, the company's existing $400 million credit facility was increased by $22.5 million to $422.5 million and the maturity date was extended to April 15, 2016.

Click here to receive FREE breaking news email alerts for BlueLinx Holdings Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.